Research analysts at StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Free Report) in a report issued on Wednesday. The brokerage set a “hold” rating on the biotechnology company’s stock.
Calithera Biosciences Price Performance
Shares of NASDAQ:CALA opened at $0.02 on Wednesday. The firm has a fifty day simple moving average of $0.02 and a two-hundred day simple moving average of $0.03. Calithera Biosciences has a 52 week low of $0.02 and a 52 week high of $0.50.
About Calithera Biosciences
Featured Articles
- Five stocks we like better than Calithera Biosciences
- Investing in Construction Stocks
- Garmin Navigates to New Highs Driven By Wearables Trend
- What is the S&P/TSX Index?
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- Are Penny Stocks a Good Fit for Your Portfolio?
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.